Monkeypox Alert: Expert-Backed Prevention Strategies to Combat the Looming Threat of the New Strain
Understanding Monkeypox: Causes, Symptoms, and Prevention Methods
Monkeypox is a viral disease caused by the Orthopoxvirus group, which also includes smallpox. It is classified into two species: clade 1 and clade 2, with clade 2B being the most widespread strain globally since 2010.
Some infected individuals may experience mild or no symptoms, with a case fatality rate of 0.2%. However, those infected with the rapidly spreading 1B clade in 2024 may exhibit more severe symptoms, including complications such as encephalitis, pneumonia, or myocarditis.
Transmission and Risk Factors
Monkeypox can be transmitted from animals to humans through contact with infected animal secretions or contaminated plants. Person-to-person transmission typically occurs through close contact with an infected individual’s secretions or droplets.
Sexual intercourse is a common mode of transmission, particularly among individuals with multiple sexual partners or those engaging in high-risk behaviors. However, there is no evidence of airborne transmission.
Symptoms and Diagnosis
Common symptoms of monkeypox include skin lesions, which may resemble bumps or blisters. These lesions typically develop into pustules, which eventually crust over and fall off.
A diagnosis can be made by swabbing the affected area to collect a sample for testing. Individuals with a history of close contact with an infected person or those who have traveled to high-risk areas may need to be quarantined in a hospital for further evaluation.
Treatment and Prevention
Currently, there is no officially approved antiviral medication for monkeypox. Treatment focuses on relieving symptoms, such as using saline solution, wound dressings, and ointments to manage skin lesions.
Vaccination is available to prevent infection, particularly for individuals at high risk, such as those with close contact with an infected person or those traveling to high-risk areas. Vaccination can be administered before or after exposure, with two injections given 4 weeks apart providing 80-85% protection against the virus.
Registration for vaccination is available at the Saowapha Institute and AIDS Research Center of the Red Cross Society of Thailand.